TigerGene is a venture capital firm established in 2018 and located in Cambridge, Massachusetts. The company focuses on investing in platform technology firms, particularly those within the life sciences sector, that have the potential to develop disruptive technologies and high-growth trajectories. By identifying and supporting innovative companies with strong intellectual property portfolios, TigerGene aims to foster advancements in technology that can significantly impact various industries.
Valora Therapeutics is a biotechnology company that provides engineering of chimeric antibodies .
NanoMosaic
Series A in 2021
NanoMosaic specializes in developing innovative solutions for early illness detection, prognostic monitoring, and biomarker identification. The company utilizes a unique nanoneedle proteomic platform that facilitates protein detection and quantification on a single chip. This technology enhances the capabilities of the medical and healthcare industry by accelerating the discovery and validation of biomarkers, thereby improving early disease detection and monitoring. Through its advanced proteomic system, NanoMosaic aims to contribute significantly to advancements in medical diagnostics and patient care.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.